The White House on Thursday announced that it has finalized negotiations with the manufacturers of the 10 drugs selected for the first round of drug price negotiation under the Biden Administration’s Inflation Reduction Act of 2022 (IRA), which the Administration said will save $1.5 billion in out-of-pocket costs for prescription drugs for people on Medicare and will save Medicare $6 billion “in the first year alone.”

Full Article Available Here